Another year in limbo post Offering.
Please cease cluttering this Board with SPAM.
Already doubled this year. Forecast very positive. Expect share price progression going forward.
Sentiment: Strong Buy
I suspect much of the reason for the RNN pullback could be the hostile business practices of Valiant casting a bad light over biotechs. Won't last, neither will this buying opportunity.
Note the SA article Rexahn's Human Data Confirms Anti-Cancer Advantage Yahoo does not allow posting link!!